Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Lymphoma, Non-Hodgkin 767Lymphoma 713Leukemia, Lymphocytic, Chronic, B-Cell 560Lymphoma, Follicular 515Lymphoma, Large B-Cell, Diffuse 440Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Recurrence 317Lymphoma, B-Cell 294Neoplasms 261Lymphoma, Mantle-Cell 251Leukemia 231Multiple Myeloma 189Hodgkin Disease 179Leukemia, Myeloid, Acute 178Lymphoma, B-Cell, Marginal Zone 135Lymphoma, T-Cell, Peripheral 119Burkitt Lymphoma 105Myelodysplastic Syndromes 101Hematologic Neoplasms 100Lymphoma, T-Cell, Cutaneous 88Waldenstrom Macroglobulinemia 84Leukemia, B-Cell 79Lymphoma, T-Cell 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65Lymphoproliferative Disorders 57Hematologic Diseases 57Melanoma 54Carcinoma, Non-Small-Cell Lung 54Breast Neoplasms 51Mycosis Fungoides 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Paraparesis, Tropical Spastic × Lymphoid × Clear all
NCT03226119 2018-09-13

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

MP Biomedicals, LLC

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT03146013 2017-06-12

Dual Algorithm Post Market Clinical Study

MP Biomedicals, LLC

Completed
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

NCT01467024 2011-11-08

Evaluation of the MP Diagnostics HTLV Blot 2.4

MP Biomedicals, LLC

Unknown
600 enrolled
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, HTLV-II Infections, Paraparesis, Tropical Spastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡